IMAX Corporation (NYSE:IMAX – Get Free Report) CEO Richard Gelfond sold 6,924 shares of the company’s stock in a transaction that occurred on Tuesday, April 14th. The stock was sold at an average price of $37.07, for a total transaction of $256,672.68. Following the transaction, the chief executive officer owned 765,002 shares of the company’s stock, valued at approximately $28,358,624.14. This represents a 0.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
IMAX Price Performance
IMAX stock opened at $34.95 on Friday. The company has a 50 day simple moving average of $38.21 and a 200 day simple moving average of $36.16. The stock has a market cap of $1.89 billion, a price-to-earnings ratio of 56.37, a P/E/G ratio of 1.69 and a beta of 0.41. IMAX Corporation has a 1 year low of $21.86 and a 1 year high of $43.16.
IMAX (NYSE:IMAX – Get Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.15. IMAX had a net margin of 8.50% and a return on equity of 13.53%. The business had revenue of $125.21 million during the quarter, compared to analysts’ expectations of $120.30 million. During the same period in the prior year, the company earned $0.27 EPS. The firm’s quarterly revenue was up 35.1% compared to the same quarter last year. On average, equities research analysts anticipate that IMAX Corporation will post 0.91 EPS for the current fiscal year.
Institutional Investors Weigh In On IMAX
Analysts Set New Price Targets
IMAX has been the subject of several recent research reports. Wall Street Zen cut shares of IMAX from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 28th. Barrington Research restated an “outperform” rating and issued a $42.00 price target on shares of IMAX in a research report on Monday, January 26th. Macquarie Infrastructure upped their price target on shares of IMAX from $39.00 to $44.00 and gave the company an “outperform” rating in a research report on Thursday, January 15th. Weiss Ratings restated a “buy (b)” rating on shares of IMAX in a research report on Monday, December 29th. Finally, JPMorgan Chase & Co. upped their price target on shares of IMAX from $47.00 to $48.00 and gave the company an “overweight” rating in a research report on Thursday, February 26th. Ten investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, IMAX has an average rating of “Moderate Buy” and a consensus target price of $43.70.
View Our Latest Analysis on IMAX
IMAX Company Profile
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Featured Stories
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
